After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

INTEGRATION Annual Project Meeting Y3

The INTEGRATION consortium held its annual meeting of the third year of the project on 21st and 22nd March 2024 in Paris. The INTEGRATION project involves the University of Sciences, Techniques

Read More

EXCO2019, the first and only global expo dedicated to the players active in the field of development cooperation

R-Evolution Worldwide Community Interest Company joined in EXCO2019, the first and only global expo dedicated to the innovative solutions provided by the actors of development cooperation: national and international agencies,

Read More

Gloria Mason, Director for the Liberia National Ethics Review Board and member of the LiberHetica, speaker at international seminars on ethics in data sharing

Proud to have Gloria Mason, Director for the Liberia National Ethics Review Board and member of the LiberHetica (http://liberhetica.org) project in the panel of joint online seminars examining the GFBR

Read More